Identification of c-Kit gene mutations in patients with polycythemia vera
- 31 October 2006
- journal article
- other
- Published by Elsevier BV in Leukemia Research
- Vol. 30 (10), 1325-1326
- https://doi.org/10.1016/j.leukres.2005.12.020
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Mutations of genes in the receptor tyrosine kinase (RTK)/RAS-BRAF signal transduction pathway in therapy-related myelodysplasia and acute myeloid leukemiaLeukemia, 2005
- A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia veraNature, 2005
- Structural Basis for the Autoinhibition and STI-571 Inhibition of c-Kit Tyrosine KinaseJournal of Biological Chemistry, 2004
- A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinibBlood, 2004
- Imatinib mesylate inhibits autonomous erythropoiesis in patients with polycythemia vera in vitroBlood, 2003
- Results of imatinib mesylate therapy in patients with refractory or recurrent acute myeloid leukemia, high‐risk myelodysplastic syndrome, and myeloproliferative disordersCancer, 2003
- Effect of tyrosine kinase inhibitor STI571 on the kinase activity of wild-type and various mutated c-kit receptors found in mast cell neoplasmsOncogene, 2003
- Familial gastrointestinal stromal tumors associated with dysphagia and novel type germline mutation of KIT geneGastroenterology, 2002
- Activating and dominant inactivating c-KITcatalytic domain mutations in distinct clinical forms of human mastocytosisProceedings of the National Academy of Sciences, 1999
- A new c‐kit mutation in a case of aggressive mast cell diseaseBritish Journal of Haematology, 1997